42 F
Ottumwa
Wednesday, November 18, 2026
Home Local News Featured Stories Grassley-Backed Bills Aim to Lower Prescription Drug Costs

Grassley-Backed Bills Aim to Lower Prescription Drug Costs

0
3

Senate Judiciary Committee Chairman Chuck Grassley (R-Iowa) today chaired a hearing to examine the high cost of prescription drugs and proposed legislative solutions. Last year, the Judiciary Committee advanced six Grassley-backed, bipartisan bills to lower prescription drug prices through competition transparency and to address anticompetitive tactics in the pharmaceutical supply chain. One of those bills, the Affordable Prescriptions for Patients Act, passed the Senate unanimously in July. The remaining bills have not received a vote on the Senate floor.

Today’s witnesses urged Congress to pass bipartisan legislation and echoed Grassley’s calls for the Federal Trade Commission (FTC) to complete its 6(b)  study of pharmacy benefit managers (PBMs). The witnesses also detailed how PBMs increase the cost of prescription drugs and outlined mechanisms to hold PBMs accountable.

Grassley questioned the following witnesses:

  • Matthew Pitlick, PharmD, chief executive officer of the Iowa Pharmacy Association
  • Merith Basey, chief executive officer of Patients For Affordable Drugs Now
  • Alex Oshmyansky, MD, PhD, cofounder and chief executive officer of the Mark Cuban Cost Plus Drug Company
  • Neeraj Sood, PhD, senior scholar and professor at the University of Southern California Shaeffer Institute for Public Policy & Government Service

Video and excerpts of Grassley’s questions follow. Read Grassley’s opening statement HERE.

LEAVE A REPLY

Please enter your comment!
Please enter your name here